| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.79B | +15.6% |
| R&D Expense | $343.0M | +5.9% |
| SG&A Expense | $2.08B | +19.9% |
| Operating Income | $162.0M | +24.6% |
| Interest Expense | $399.0M | +41.0% |
| Pre-tax Income | -$234.0M | -41.0% |
| Income Tax | $71.0M | -13.4% |
| Net Income | -$317.0M | -21.9% |
| EPS (Basic) | -$0.90 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $305.0M | -7.9% |
| Accounts Receivable | $1.03B | +22.3% |
| Inventory | $1.04B | +0.8% |
| Current Assets | $2.79B | +1.7% |
| Total Assets | $13.47B | +0.2% |
| Current Liabilities | $1.74B | +10.1% |
| Long-term Debt | $4.78B | +4.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $232.0M | +1464.7% |
| Capital Expenditures | $291.0M | +60.8% |
| Investing Cash Flow | -$412.0M | +80.5% |
| Financing Cash Flow | $178.0M | -91.4% |
| Free Cash Flow | -$59.0M | +70.2% |
| -21.6% |
| EPS (Diluted) | -$0.90 | -21.6% |
| Total Liabilities |
| $6.92B |
| +6.2% |
| Stockholders' Equity | $6.47B | -5.5% |